Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53-Reference-Cited by-同舟云学术

Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53

Published:2000-12-13 Issue:2 Volume:40 Page:336-344
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Stoll Raphael¹,Renner Christian¹,Hansen Silke¹,Palme Stefan¹,Klein Christian¹,Belling Anja¹,Zeslawski Wojciech¹,Kamionka Mariusz¹,Rehm Till¹,Mühlhahn Peter¹,Schumacher Ralf¹,Hesse Friederike¹,Kaluza Brigitte¹,Voelter Wolfgang¹,Engh Richard A.¹,Holak Tad A.¹

Affiliation:

1. Max Planck Institute of Biochemistry, D-82152 Martinsried, Germany, Roche Diagnostics GmbH, Pharmaceutical Research, D-82372 Penzberg, Germany, and Tübingen University, Department of Physical Biochemistry, Institute of Physiological Chemistry, D-72076 Tübingen, Germany

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi000930v

Reference41 articles.

1. Amplification of a gene encoding a p53-associated protein in human sarcomas

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction;Bioorganic Chemistry;2024-12

2. MDM2: current research status and prospects of tumor treatment;Cancer Cell International;2024-05-13

3. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15

4. A Novel MDM2-Binding Chalcone Induces Apoptosis of Oral Squamous Cell Carcinoma;Biomedicines;2023-06-14

5. Bourgeoning Cancer Targets;Recent Patents on Anti-Cancer Drug Discovery;2023-05